{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:14:43Z","timestamp":1790079283682,"version":"4.0.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12778-8","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:41:39Z","timestamp":1790077299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BRD proteins in human retroviral infection: emerging evidence from HIV-1 and future perspectives for HTLV-1"],"prefix":"10.1007","volume":"53","author":[{"given":"Mohammad Mehdi","family":"Akbarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Farjami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1682-8104","authenticated-orcid":false,"given":"Hugo Ram\u00edrez","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"3","key":"12778_CR1","doi-asserted-by":"publisher","first-page":"167924","DOI":"10.1016\/j.jmb.2022.167924","volume":"435","author":"A Chameettachal","year":"2023","unstructured":"Chameettachal A, Mustafa F, Rizvi TA (2023) Understanding Retroviral Life Cycle and its Genomic RNA Packaging. J Mol Biol 435(3):167924. https:\/\/doi.org\/10.1016\/j.jmb.2022.167924","journal-title":"J Mol Biol"},{"key":"12778_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/brv.70188","author":"MA Jehad","year":"2026","unstructured":"Jehad MA, Prabhu SG, Ali LM, Pillai VN, Mustafa F, Rizvi TA (2026) RNA-centric world of retroviruses: unravelling the molecular strategies of genomic RNA packaging. Biol Rev Camb Philos Soc. https:\/\/doi.org\/10.1002\/brv.70188","journal-title":"Biol Rev Camb Philos Soc"},{"key":"12778_CR3","doi-asserted-by":"publisher","unstructured":"Reddy K, Reddy N, Ndung\u2019u T (2026) The Implications of HIV-1 Subtypes on Pathogenesis, Reservoirs and Cure Strategies. Curr HIV\/AIDS Rep 23(1). https:\/\/doi.org\/10.1007\/s11904-026-00780-5","DOI":"10.1007\/s11904-026-00780-5"},{"key":"12778_CR4","doi-asserted-by":"publisher","unstructured":"Branda F, Romano C, Pavia G, Bilotta V, Locci C, Azzena I et al (2025) Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges. Viruses 17(5). https:\/\/doi.org\/10.3390\/v17050664","DOI":"10.3390\/v17050664"},{"key":"12778_CR5","doi-asserted-by":"publisher","unstructured":"Johnston CD, Petersen KJ, Corley MJ (2026) Epigenetic aging is a hallmark of HIV pathogenesis and phenotypic outcomes. Curr HIV\/AIDS Rep 23(1). https:\/\/doi.org\/10.1007\/s11904-026-00781-4","DOI":"10.1007\/s11904-026-00781-4"},{"key":"12778_CR6","doi-asserted-by":"publisher","first-page":"105622","DOI":"10.1016\/j.micpath.2022.105622","volume":"169","author":"S Ramezani","year":"2022","unstructured":"Ramezani S, Rezaee SA, Farjami Z, Ebrahimi N, Abdullabass HK, Ibrahim Jebur MI et al (2022) HTLV, a multi organ oncovirus. Microb Pathog 169:105622. https:\/\/doi.org\/10.1016\/j.micpath.2022.105622","journal-title":"Microb Pathog"},{"issue":"4","key":"12778_CR7","doi-asserted-by":"publisher","first-page":"e2567","DOI":"10.1002\/rmv.2567","volume":"34","author":"S Ahmadi Ghezeldasht","year":"2024","unstructured":"Ahmadi Ghezeldasht S, Mosavat A, Rezaee SA (2024) Novel insights into human T-lymphotropic virus type-1 (HTLV-1) pathogenesis-host interactions in the manifestation of HTLV-1-associated myelopathy\/tropical spastic paraparesis. Rev Med Virol 34(4):e2567. https:\/\/doi.org\/10.1002\/rmv.2567","journal-title":"Rev Med Virol"},{"issue":"1","key":"12778_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11033-025-11216-5","volume":"53","author":"MM Akbarin","year":"2025","unstructured":"Akbarin MM, Farjami Z, Acevedo-Jimenez GE, Murillo CR, Gonzalez-Fernandez VD, de Maria Avila-De, la Vega L et al (2025) BCL-2 family dysregulation in HTLV-1 and BLV pathogenesis and its implications for leukemogenesis and therapy. Mol Biol Rep 53(1):61. https:\/\/doi.org\/10.1007\/s11033-025-11216-5","journal-title":"Mol Biol Rep"},{"key":"12778_CR9","doi-asserted-by":"publisher","unstructured":"Farjami Z, Akbarin MM (2026) Exploitation of CREB signaling by HTLV-1 and BLV: A central axis in viral persistence and leukemogenesis. Med Oncol 43(4). https:\/\/doi.org\/10.1007\/s12032-026-03282-x","DOI":"10.1007\/s12032-026-03282-x"},{"issue":"1","key":"12778_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s11033-026-11513-7","volume":"53","author":"Z Farjami","year":"2026","unstructured":"Farjami Z, Akbarin MM, Alvarez HR (2026) Suppressor of cytokine signaling (SOCS) proteins in human retroviral infections. Mol Biol Rep 53(1):366. https:\/\/doi.org\/10.1007\/s11033-026-11513-7","journal-title":"Mol Biol Rep"},{"key":"12778_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-026-07087-w","author":"MM Akbarin","year":"2026","unstructured":"Akbarin MM, Farjami Z, Alvarez HR (2026) Exploiting the Notch pathway in HTLV-1-driven adult T-cell leukemia\/lymphoma: a mini-review. Ann Hematol. https:\/\/doi.org\/10.1007\/s00277-026-07087-w","journal-title":"Ann Hematol"},{"issue":"1","key":"12778_CR12","first-page":"88","volume":"6","author":"R Torshizi","year":"2017","unstructured":"Torshizi R, Ghayour Karimani E, Etminani K, Akbarin MM, Jamialahmadi K, Shirdel A et al (2017) Altered Expression of Cell Cycle Regulators in Adult T-Cell Leukemia\/ Lymphoma Patients. Rep Biochem Mol Biol 6(1):88\u201394","journal-title":"Rep Biochem Mol Biol"},{"key":"12778_CR13","doi-asserted-by":"publisher","first-page":"636642","DOI":"10.3389\/fmicb.2021.636642","volume":"12","author":"J Janssens","year":"2021","unstructured":"Janssens J, Bruggemans A, Christ F, Debyser Z (2021) Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus. Front Microbiol 12:636642. https:\/\/doi.org\/10.3389\/fmicb.2021.636642","journal-title":"Front Microbiol"},{"key":"12778_CR14","doi-asserted-by":"publisher","unstructured":"Li C, Ma Y, Mori LP, Yang H, Wang Y, Venables TT et al (2025) The human chromatin remodeling complex p400 restricts HIV-1 transcription in a Tat-dependent manner. Nucleic Acids Res 53(22). https:\/\/doi.org\/10.1093\/nar\/gkaf1323","DOI":"10.1093\/nar\/gkaf1323"},{"issue":"6","key":"12778_CR15","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/v5061571","volume":"5","author":"D Boehm","year":"2013","unstructured":"Boehm D, Conrad RJ, Ott M (2013) Bromodomain proteins in HIV infection. Viruses 5(6):1571\u20131586. https:\/\/doi.org\/10.3390\/v5061571","journal-title":"Viruses"},{"issue":"21","key":"12778_CR16","doi-asserted-by":"publisher","first-page":"e2418467122","DOI":"10.1073\/pnas.2418467122","volume":"122","author":"TY Luk","year":"2025","unstructured":"Luk TY, Yim LY, Zhou R, Mo Y, Huang H, Zhao M et al (2025) BRD9 functions as an HIV-1 latency regulatory factor. Proc Natl Acad Sci U S A 122(21):e2418467122. https:\/\/doi.org\/10.1073\/pnas.2418467122","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"12778_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/AID.2023.0025","volume":"40","author":"Z Fajami","year":"2024","unstructured":"Fajami Z, Akbarin MM, Rafatpanah H, Ramezani S, Rahimi H, Rezaee SA (2024) Assessment of Bcl-xL, TAX, and HBZ Gene Expression in Adult T cell Leukemia\/Lymphoma Patients. AIDS Res Hum Retroviruses 40(3):141\u2013147. https:\/\/doi.org\/10.1089\/AID.2023.0025","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"12778_CR18","doi-asserted-by":"publisher","first-page":"e0229498","DOI":"10.1371\/journal.pone.0229498","volume":"15","author":"PO Editors","year":"2020","unstructured":"Editors PO (2020) Expression of Concern: HTLV-1 Tax Mediated Downregulation of miRNAs Associated with Chromatin Remodeling Factors in T Cells with Stably Integrated Viral Promoter. PLoS ONE 15(2):e0229498. https:\/\/doi.org\/10.1371\/journal.pone.0229498","journal-title":"PLoS ONE"},{"issue":"4","key":"12778_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","volume":"19","author":"Z Yang","year":"2005","unstructured":"Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K et al (2005) Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 19(4):535\u2013545. https:\/\/doi.org\/10.1016\/j.molcel.2005.06.029","journal-title":"Mol Cell"},{"issue":"34","key":"12778_CR20","doi-asserted-by":"publisher","first-page":"13690","DOI":"10.1073\/pnas.0705053104","volume":"104","author":"DA Bisgrove","year":"2007","unstructured":"Bisgrove DA, Mahmoudi T, Henklein P, Verdin E (2007) Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc Natl Acad Sci U S A 104(34):13690\u201313695. https:\/\/doi.org\/10.1073\/pnas.0705053104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"12778_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2017.07.025","volume":"67","author":"RJ Conrad","year":"2017","unstructured":"Conrad RJ, Fozouni P, Thomas S, Sy H, Zhang Q, Zhou MM et al (2017) The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI\/SNF Chromatin-Remodeling Complexes. Mol Cell 67(6):1001\u201312e6. https:\/\/doi.org\/10.1016\/j.molcel.2017.07.025","journal-title":"Mol Cell"},{"issue":"20","key":"12778_CR22","doi-asserted-by":"publisher","first-page":"11179","DOI":"10.1128\/JVI.00408-07","volume":"81","author":"WK Cho","year":"2007","unstructured":"Cho WK, Zhou M, Jang MK, Huang K, Jeong SJ, Ozato K et al (2007) Modulation of the Brd4\/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein. J Virol 81(20):11179\u201311186. https:\/\/doi.org\/10.1128\/JVI.00408-07","journal-title":"J Virol"},{"issue":"24","key":"12778_CR23","doi-asserted-by":"publisher","first-page":"12801","DOI":"10.1128\/JVI.00943-10","volume":"84","author":"WK Cho","year":"2010","unstructured":"Cho WK, Jang MK, Huang K, Pise-Masison CA, Brady JN (2010) Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP\/HEXIM1 binding. J Virol 84(24):12801\u201312809. https:\/\/doi.org\/10.1128\/JVI.00943-10","journal-title":"J Virol"},{"issue":"12","key":"12778_CR24","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.stemcr.2022.10.005","volume":"17","author":"K Sevinc","year":"2022","unstructured":"Sevinc K, Sevinc GG, Cavga AD, Philpott M, Kelekci S, Can H et al (2022) BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming. Stem Cell Rep 17(12):2629\u20132642. https:\/\/doi.org\/10.1016\/j.stemcr.2022.10.005","journal-title":"Stem Cell Rep"},{"issue":"7","key":"12778_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41418-024-01306-5","volume":"31","author":"S Garg","year":"2024","unstructured":"Garg S, Ni W, Chowdhury B, Weisberg EL, Sattler M, Griffin JD (2024) BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation. Cell Death Differ 31(7):868\u2013880. https:\/\/doi.org\/10.1038\/s41418-024-01306-5","journal-title":"Cell Death Differ"},{"issue":"1","key":"12778_CR26","doi-asserted-by":"publisher","first-page":"15360","DOI":"10.1038\/s41598-022-19648-w","volume":"12","author":"NK Mair","year":"2022","unstructured":"Mair NK, Hale BG, Ultra-Rare BRD (2022) 9 Loss-of-Function Variants Limit the Antiviral Action of Interferon. Sci Rep 12(1):15360. https:\/\/doi.org\/10.1038\/s41598-022-19648-w","journal-title":"Sci Rep"},{"issue":"6","key":"12778_CR27","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1021\/acs.jmedchem.9b01980","volume":"63","author":"RM Karim","year":"2020","unstructured":"Karim RM, Chan A, Zhu JY, Schonbrunn E (2020) Structural Basis of Inhibitor Selectivity in the BRD7\/9 Subfamily of Bromodomains. J Med Chem 63(6):3227\u20133237. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01980","journal-title":"J Med Chem"},{"key":"12778_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2015.12.005","volume":"106","author":"E Ferri","year":"2016","unstructured":"Ferri E, Petosa C, McKenna CE (2016) Bromodomains: Structure, function and pharmacology of inhibition. Biochem Pharmacol 106:1\u201318. https:\/\/doi.org\/10.1016\/j.bcp.2015.12.005","journal-title":"Biochem Pharmacol"},{"issue":"14","key":"12778_CR29","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/cmdc.201800234","volume":"13","author":"A Dalle Vedove","year":"2018","unstructured":"Dalle Vedove A, Spiliotopoulos D, D\u2019Agostino VG, Marchand JR, Unzue A, Nevado C et al (2018) Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains. ChemMedChem 13(14):1479\u20131487. https:\/\/doi.org\/10.1002\/cmdc.201800234","journal-title":"ChemMedChem"},{"issue":"1","key":"12778_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1158\/2767-9764.crc-23-0382","volume":"4","author":"DC Klein","year":"2024","unstructured":"Klein DC, Lardo SM, Hainer SJ (2024) The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9. Cancer Res Commun 4(1):237\u2013252. https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0382","journal-title":"Cancer Res Commun"},{"issue":"1","key":"12778_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2023.09.021","volume":"166","author":"Y Feng","year":"2024","unstructured":"Feng Y, Cai L, Pook M, Liu F, Chang CH, Mouti MA et al (2024) BRD9-SMAD2\/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma. Gastroenterology 166(1):139\u2013154. https:\/\/doi.org\/10.1053\/j.gastro.2023.09.021","journal-title":"Gastroenterology"},{"issue":"9","key":"12778_CR32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1021\/acs.biochem.0c00816","volume":"60","author":"K Patel","year":"2021","unstructured":"Patel K, Solomon PD, Walshe JL, Ford DJ, Wilkinson-White L, Payne RJ et al (2021) BET-Family Bromodomains Can Recognize Diacetylated Sequences from Transcription Factors Using a Conserved Mechanism. Biochemistry 60(9):648\u2013662. https:\/\/doi.org\/10.1021\/acs.biochem.0c00816","journal-title":"Biochemistry"},{"issue":"17","key":"12778_CR33","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1021\/acs.jmedchem.0c00566","volume":"63","author":"CR Wellaway","year":"2020","unstructured":"Wellaway CR, Bamborough P, Bernard SG, Chung CW, Craggs PD, Cutler L et al (2020) Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype. J Med Chem 63(17):9020\u20139044. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00566","journal-title":"J Med Chem"},{"key":"12778_CR34","doi-asserted-by":"crossref","unstructured":"Frascatani R, Marafini I, Colella M, Monteleone G (2026) Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potential. J Inflamm-Lond 23(1). doi: ARTN 710.1186\/s12950-026-00489-7","DOI":"10.1186\/s12950-026-00489-7"},{"key":"12778_CR35","doi-asserted-by":"crossref","unstructured":"Sharma D, Bushnell GG, Kalman AP, Hutchens CM, Burness ML (2026) Bromodomain and extra-terminal proteins in solid tumors: regulators of immune microenvironment and emerging therapeutic targets. Frontiers in Immunology 16. doi: ARTN 172736510.3389\/fimmu.2025.1727365","DOI":"10.3389\/fimmu.2025.1727365"},{"issue":"7","key":"12778_CR36","doi-asserted-by":"publisher","first-page":"030006052614652","DOI":"10.1177\/03000605261465295","volume":"54","author":"KX Zhang","year":"2026","unstructured":"Zhang KX, Fan YK, Wang Y (2026) Targeting bromodomain and extraterminal proteins in cardiovascular disease: Pathological mechanisms and therapeutic applications. J Int Med Res 54(7):03000605261465295 Artn 0300060526146529510.1177\/03000605261465295","journal-title":"J Int Med Res"},{"issue":"9","key":"12778_CR37","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/leu.2016.393","volume":"31","author":"DT Saenz","year":"2017","unstructured":"Saenz DT, Fiskus W, Qian Y, Manshouri T, Rajapakshe K, Raina K et al (2017) Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells. Leukemia 31(9):1951\u20131961. https:\/\/doi.org\/10.1038\/leu.2016.393","journal-title":"Leukemia"},{"key":"12778_CR38","doi-asserted-by":"publisher","unstructured":"Saenz DT, Fiskus W, Raina K, Manshouri T, Coleman K, Winkler J et al (2016) Superior Lethal Activity of Novel BET Protein Proteolysis Targeting Chimera (BETP-PROTACs) Versus Betp Bromodomain Inhibitor (BETi) Against Post-Myeloproliferative Neoplasm (MPN) Secondary (s) AML Cells. Blood 128(22). https:\/\/doi.org\/10.1182\/blood.V128.22.747.747","DOI":"10.1182\/blood.V128.22.747.747"},{"key":"12778_CR39","doi-asserted-by":"publisher","unstructured":"Saenz DT, Fiskus WC, Raina K, Manshouri T, Coleman KG, Qian YM et al (2017) BET protein proteolysis targeting chimera (BETP-PROTACs) exert more potent activity than BETP bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm (MPN) secondary (s) AML cells. Cancer Res 77. https:\/\/doi.org\/10.1158\/1538-7445.Am2017-5067","DOI":"10.1158\/1538-7445.Am2017-5067"},{"issue":"3","key":"12778_CR40","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/jcp.26010","volume":"233","author":"JT Lloyd","year":"2018","unstructured":"Lloyd JT, Glass KC (2018) Biological function and histone recognition of family IV bromodomain-containing proteins. J Cell Physiol 233(3):1877\u20131886. https:\/\/doi.org\/10.1002\/jcp.26010","journal-title":"J Cell Physiol"},{"issue":"2","key":"12778_CR41","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/pro.4006","volume":"30","author":"K Patel","year":"2021","unstructured":"Patel K, Solomon PD, Walshe JL, Low JKK, Mackay JP (2021) The bromodomains of BET family proteins can recognize diacetylated histone H2A.Z. Protein Sci 30(2):464\u2013476. https:\/\/doi.org\/10.1002\/pro.4006","journal-title":"Protein Sci"},{"key":"12778_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1101\/sqb.2016.81.031021","volume":"81","author":"JL Pulice","year":"2016","unstructured":"Pulice JL, Kadoch C (2016) Composition and Function of Mammalian SWI\/SNF Chromatin Remodeling Complexes in Human Disease. Cold Spring Harb Symp Quant Biol 81:53\u201360. https:\/\/doi.org\/10.1101\/sqb.2016.81.031021","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"29","key":"12778_CR43","doi-asserted-by":"publisher","first-page":"11497","DOI":"10.1021\/jacs.9b02738","volume":"141","author":"X Li","year":"2019","unstructured":"Li X, Wu Y, Tian G, Jiang Y, Liu Z, Meng X et al (2019) Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells. J Am Chem Soc 141(29):11497\u201311505. https:\/\/doi.org\/10.1021\/jacs.9b02738","journal-title":"J Am Chem Soc"},{"issue":"6","key":"12778_CR44","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1080\/07391102.2023.2212796","volume":"42","author":"ZD Chen","year":"2024","unstructured":"Chen ZD, Li YX, Wang XP, Qiu XH, Wang CL, Wang Z et al (2024) A high-throughput molecular dynamics screening (HTMDS) approach to the design of novel cyclopeptide inhibitors of ATAD2B based on the non-canonical combinatorial library. J Biomol Struct Dyn 42(6):2809\u20132824. https:\/\/doi.org\/10.1080\/07391102.2023.2212796","journal-title":"J Biomol Struct Dyn"},{"key":"12778_CR45","doi-asserted-by":"crossref","unstructured":"Yang XT, Gao YL, Cao FY, Wang S (2023) Molecular Dynamics Simulations Combined with Markov Model to Explore the Effect of Allosteric Inhibitor Binding on Bromodomain-Containing Protein 4. International Journal of Molecular Sciences. ;24(13). doi: ARTN 1083110.3390\/ijms241310831","DOI":"10.3390\/ijms241310831"},{"issue":"7","key":"12778_CR46","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1158\/1541-7786.MCR-18-1121","volume":"17","author":"SM Bevill","year":"2019","unstructured":"Bevill SM, Olivares-Quintero JF, Sciaky N, Golitz BT, Singh D, Beltran AS et al (2019) GSK2801, a BAZ2\/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer. Mol Cancer Res 17(7):1503\u20131518. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-1121","journal-title":"Mol Cancer Res"},{"key":"12778_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.scr.2018.09.004","volume":"32","author":"T Trost","year":"2018","unstructured":"Trost T, Haines J, Dillon A, Mersman B, Robbins M, Thomas P et al (2018) Characterizing the role of SWI\/SNF-related chromatin remodeling complexes in planarian regeneration and stem cell function. Stem Cell Res 32:91\u2013103. https:\/\/doi.org\/10.1016\/j.scr.2018.09.004","journal-title":"Stem Cell Res"},{"key":"12778_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-026-03534-7","author":"B Grothey","year":"2026","unstructured":"Grothey B, Kr\u00e4mer M, Montalbano M, Lyu SI, Bruns CJ, Zander T et al (2026) Proteomic characterization of SMARCA-deficient esophageal adenocarcinoma reveals complement evasion and DNA repair-associated prognostic subgroups. Brit J Cancer. https:\/\/doi.org\/10.1038\/s41416-026-03534-7","journal-title":"Brit J Cancer"},{"key":"12778_CR49","doi-asserted-by":"publisher","first-page":"105480","DOI":"10.1016\/j.bioorg.2021.105480","volume":"118","author":"M Pierri","year":"2022","unstructured":"Pierri M, Gazzillo E, Chini MG, Ferraro MG, Piccolo M, Maione F et al (2022) Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders. Bioorg Chem 118:105480. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105480","journal-title":"Bioorg Chem"},{"key":"12778_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-026-02224-y","author":"VA Spiteri","year":"2026","unstructured":"Spiteri VA, Segal D, Correa-S\u00e1ez A, Iso K, Casement R, Ordo\u00f1o MMI et al (2026) Dual E3 ligase recruitment by monovalent degraders for tunable SMARCA 2\/4 degradation. Nat Chem Biol. https:\/\/doi.org\/10.1038\/s41589-026-02224-y","journal-title":"Nat Chem Biol"},{"issue":"1","key":"12778_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1021\/acsmedchemlett.3c00373","volume":"15","author":"YK Wang","year":"2024","unstructured":"Wang YK, Huang XS, Sun H, Ma MD, Yu HP, Hu W et al (2024) Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents. ACS Med Chem Lett 15(1):60\u201368. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00373","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"12778_CR52","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.immuni.2023.05.008","volume":"56","author":"AE Baxter","year":"2023","unstructured":"Baxter AE, Huang H, Giles JR, Chen Z, Wu JE, Drury S et al (2023) The SWI\/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8(+) T cells. Immunity 56(6):1320\u201340e10. https:\/\/doi.org\/10.1016\/j.immuni.2023.05.008","journal-title":"Immunity"},{"issue":"9","key":"12778_CR53","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1093\/neuonc\/noaf081","volume":"27","author":"CL Nesvick","year":"2025","unstructured":"Nesvick CL, Zhang L, Yan Y, Wixom AQ, Hamdan FH, Ge J et al (2025) SWI\/SNF complexes govern ontology-specific transcription factor function in MYC-subtype atypical teratoid rhabdoid tumor. Neuro Oncol 27(9):2445\u20132460. https:\/\/doi.org\/10.1093\/neuonc\/noaf081","journal-title":"Neuro Oncol"},{"key":"12778_CR54","doi-asserted-by":"publisher","first-page":"123428","DOI":"10.1016\/j.ijbiomac.2023.123428","volume":"230","author":"MM Ali","year":"2023","unstructured":"Ali MM, Naz S, Ashraf S, Knapp S, Ul-Haq Z (2023) Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition. Int J Biol Macromol 230:123428","journal-title":"Int J Biol Macromol"},{"issue":"18","key":"12778_CR55","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1073\/pnas.1120422109","volume":"109","author":"BN Devaiah","year":"2012","unstructured":"Devaiah BN, Lewis BA, Cherman N, Hewitt MC, Albrecht BK, Robey PG et al (2012) BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A 109(18):6927\u20136932. https:\/\/doi.org\/10.1073\/pnas.1120422109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"12778_CR56","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1093\/nar\/gku449","volume":"42","author":"F Itzen","year":"2014","unstructured":"Itzen F, Greifenberg AK, Bosken CA, Geyer M (2014) Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation. Nucleic Acids Res 42(12):7577\u20137590. https:\/\/doi.org\/10.1093\/nar\/gku449","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"12778_CR57","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/1570162033485186","volume":"1","author":"A Pumfery","year":"2003","unstructured":"Pumfery A, Deng L, Maddukuri A, de la Fuente C, Li H, Wade JD et al (2003) Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr HIV Res 1(3):343\u2013362. https:\/\/doi.org\/10.2174\/1570162033485186","journal-title":"Curr HIV Res"},{"issue":"13","key":"12778_CR58","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1038\/onc.2013.126","volume":"33","author":"AR Grayson","year":"2014","unstructured":"Grayson AR, Walsh EM, Cameron MJ, Godec J, Ashworth T, Ambrose JM et al (2014) MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene 33(13):1736\u20131742. https:\/\/doi.org\/10.1038\/onc.2013.126","journal-title":"Oncogene"},{"key":"12778_CR59","doi-asserted-by":"publisher","first-page":"1610447","DOI":"10.3389\/pore.2022.1610447","volume":"28","author":"K Zhang","year":"2022","unstructured":"Zhang K, Gao L, Wang J, Chu X, Zhang Z, Zhang Y et al (2022) A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells. Pathol Oncol Res 28:1610447. https:\/\/doi.org\/10.3389\/pore.2022.1610447","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"12778_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12943-025-02449-w","volume":"24","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Wang Q, Duan Y, Zhang C, Liu T, Liu H et al (2025) BRD9-p53-E2F1 circuit orchestrates cell growth and DNA damage repair in gastric cancer. Mol Cancer 24(1):239","journal-title":"Mol Cancer"},{"issue":"2","key":"12778_CR61","doi-asserted-by":"publisher","first-page":"112727","DOI":"10.1016\/j.yexcr.2021.112727","volume":"406","author":"D Fang","year":"2021","unstructured":"Fang D, Wang M-R, Guan J-L, Han Y-Y, Sheng J-Q, Tian D-A et al (2021) Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt\/\u03b2-catenin signaling pathway. Exp Cell Res 406(2):112727","journal-title":"Exp Cell Res"},{"issue":"2","key":"12778_CR62","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","volume":"34","author":"M Nakagawa","year":"2018","unstructured":"Nakagawa M, Shaffer AL 3rd, Ceribelli M, Zhang M, Wright G, Huang DW et al (2018) Targeting the HTLV-I-Regulated BATF3\/IRF4 Transcriptional Network in Adult T Cell Leukemia\/Lymphoma. Cancer Cell 34(2):286\u2013297. e10","journal-title":"Cancer Cell"},{"issue":"1","key":"12778_CR63","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/s41467-020-16443-x","volume":"11","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Huang J, Zhang C, Zhao F, Kim W, Tu X et al (2020) The bromodomain containing protein BRD-9 orchestrates RAD51\u2013RAD54 complex formation and regulates homologous recombination-mediated repair. Nat Commun 11(1):2639","journal-title":"Nat Commun"},{"key":"12778_CR64","doi-asserted-by":"publisher","DOI":"10.1101\/2023.03.02.530770","author":"Y Feng","year":"2023","unstructured":"Feng Y, Cai L, Pook M, Liu F, Chang CH, Mouti MA et al (2023) BRD9-SMAD2\/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma. bioRxiv. https:\/\/doi.org\/10.1101\/2023.03.02.530770","journal-title":"bioRxiv"},{"issue":"23","key":"12778_CR65","doi-asserted-by":"publisher","first-page":"12721","DOI":"10.1128\/JVI.01942-13","volume":"87","author":"SS Gupta","year":"2013","unstructured":"Gupta SS, Maetzig T, Maertens GN, Sharif A, Rothe M, Weidner-Glunde M et al (2013) Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J Virol 87(23):12721\u201312736. https:\/\/doi.org\/10.1128\/JVI.01942-13","journal-title":"J Virol"},{"issue":"3","key":"12778_CR66","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/cc.23309","volume":"12","author":"D Boehm","year":"2013","unstructured":"Boehm D, Calvanese V, Dar RD, Xing S, Schroeder S, Martins L et al (2013) BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle 12(3):452\u2013462. https:\/\/doi.org\/10.4161\/cc.23309","journal-title":"Cell Cycle"},{"issue":"16","key":"12778_CR67","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.1074\/jbc.RA118.002353","volume":"293","author":"GR Campbell","year":"2018","unstructured":"Campbell GR, Bruckman RS, Herns SD, Joshi S, Durden DL, Spector SA (2018) Induction of autophagy by PI3K\/MTOR and PI3K\/MTOR\/BRD4 inhibitors suppresses HIV-1 replication. J Biol Chem 293(16):5808\u20135820. https:\/\/doi.org\/10.1074\/jbc.RA118.002353","journal-title":"J Biol Chem"},{"issue":"4","key":"12778_CR68","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/anie.201807825","volume":"58","author":"M D\u2019Ascenzio","year":"2019","unstructured":"D\u2019Ascenzio M, Pugh KM, Konietzny R, Berridge G, Tallant C, Hashem S et al (2019) An Activity-Based Probe Targeting Non-Catalytic, Highly Conserved Amino Acid Residues within Bromodomains. Angew Chem Int Ed Engl 58(4):1007\u20131012. https:\/\/doi.org\/10.1002\/anie.201807825","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"12778_CR69","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0014-5793(01)03309-9","volume":"513","author":"L Zeng","year":"2002","unstructured":"Zeng L, Zhou MM (2002) Bromodomain: an acetyl-lysine binding domain. FEBS Lett 513(1):124\u2013128. https:\/\/doi.org\/10.1016\/s0014-5793(01)03309-9","journal-title":"FEBS Lett"},{"issue":"50","key":"12778_CR70","doi-asserted-by":"publisher","first-page":"36094","DOI":"10.1074\/jbc.M113.485029","volume":"288","author":"X Wu","year":"2013","unstructured":"Wu X, Qi J, Bradner JE, Xiao G, Chen LF (2013) Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor kappaB (NF-kappaB) signaling. J Biol Chem 288(50):36094\u201336105. https:\/\/doi.org\/10.1074\/jbc.M113.485029","journal-title":"J Biol Chem"},{"issue":"1","key":"12778_CR71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12943-020-01254-x","volume":"19","author":"CH Yeh","year":"2020","unstructured":"Yeh CH, Bellon M, Wang F, Zhang H, Fu L, Nicot C (2020) Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells. Mol Cancer 19(1):139. https:\/\/doi.org\/10.1186\/s12943-020-01254-x","journal-title":"Mol Cancer"},{"key":"12778_CR72","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.2741\/1994","volume":"11","author":"RM Marshall","year":"2006","unstructured":"Marshall RM, Grana X (2006) Mechanisms controlling CDK9 activity. Front Biosci 11:2598\u20132613. https:\/\/doi.org\/10.2741\/1994","journal-title":"Front Biosci"},{"issue":"3","key":"12778_CR73","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1128\/MMBR.00011-06","volume":"70","author":"Q Zhou","year":"2006","unstructured":"Zhou Q, Yik JH (2006) The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol Mol Biol Rev 70(3):646\u2013659. https:\/\/doi.org\/10.1128\/MMBR.00011-06","journal-title":"Microbiol Mol Biol Rev"},{"issue":"29","key":"12778_CR74","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1016\/j.febslet.2008.10.047","volume":"582","author":"E Urano","year":"2008","unstructured":"Urano E, Kariya Y, Futahashi Y, Ichikawa R, Hamatake M, Fukazawa H et al (2008) Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells. FEBS Lett 582(29):4053\u20134058. https:\/\/doi.org\/10.1016\/j.febslet.2008.10.047","journal-title":"FEBS Lett"},{"issue":"2","key":"12778_CR75","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1128\/JVI.01316-08","volume":"83","author":"M Zhou","year":"2009","unstructured":"Zhou M, Huang K, Jung KJ, Cho WK, Klase Z, Kashanchi F et al (2009) Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. J Virol 83(2):1036\u20131044. https:\/\/doi.org\/10.1128\/JVI.01316-08","journal-title":"J Virol"},{"issue":"8","key":"12778_CR76","doi-asserted-by":"publisher","first-page":"e12335","DOI":"10.1371\/journal.pone.0012335","volume":"5","author":"BJ Krueger","year":"2010","unstructured":"Krueger BJ, Varzavand K, Cooper JJ, Price DH (2010) The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK. PLoS ONE 5(8):e12335. https:\/\/doi.org\/10.1371\/journal.pone.0012335","journal-title":"PLoS ONE"},{"issue":"22","key":"12778_CR77","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1093\/nar\/gkr698","volume":"39","author":"N Ai","year":"2011","unstructured":"Ai N, Hu X, Ding F, Yu B, Wang H, Lu X et al (2011) Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation. Nucleic Acids Res 39(22):9592\u20139604. https:\/\/doi.org\/10.1093\/nar\/gkr698","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"12778_CR78","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1074\/jbc.M111.282855","volume":"287","author":"S Schroder","year":"2012","unstructured":"Schroder S, Cho S, Zeng L, Zhang Q, Kaehlcke K, Mak L et al (2012) Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes. J Biol Chem 287(2):1090\u20131099. https:\/\/doi.org\/10.1074\/jbc.M111.282855","journal-title":"J Biol Chem"},{"issue":"1","key":"12778_CR79","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1073\/pnas.1318503111","volume":"111","author":"H Lu","year":"2014","unstructured":"Lu H, Li Z, Xue Y, Schulze-Gahmen U, Johnson JR, Krogan NJ et al (2014) AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation. Proc Natl Acad Sci U S A 111(1):E15\u201324. https:\/\/doi.org\/10.1073\/pnas.1318503111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"12778_CR80","doi-asserted-by":"publisher","first-page":"36609","DOI":"10.1074\/jbc.M112.410746","volume":"287","author":"K Bartholomeeusen","year":"2012","unstructured":"Bartholomeeusen K, Xiang Y, Fujinaga K, Peterlin BM (2012) Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein. J Biol Chem 287(43):36609\u201336616. https:\/\/doi.org\/10.1074\/jbc.M112.410746","journal-title":"J Biol Chem"},{"issue":"4","key":"12778_CR81","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.celrep.2012.09.008","volume":"2","author":"J Zhu","year":"2012","unstructured":"Zhu J, Gaiha GD, John SP, Pertel T, Chin CR, Gao G et al (2012) Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep 2(4):807\u2013816. https:\/\/doi.org\/10.1016\/j.celrep.2012.09.008","journal-title":"Cell Rep"},{"issue":"1","key":"12778_CR82","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/nar\/gks976","volume":"41","author":"Z Li","year":"2013","unstructured":"Li Z, Guo J, Wu Y, Zhou Q (2013) The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic Acids Res 41(1):277\u2013287. https:\/\/doi.org\/10.1093\/nar\/gks976","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"12778_CR83","doi-asserted-by":"publisher","first-page":"e1007012","DOI":"10.1371\/journal.ppat.1007012","volume":"14","author":"Z Li","year":"2018","unstructured":"Li Z, Mbonye U, Feng Z, Wang X, Gao X, Karn J et al (2018) The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency. PLoS Pathog 14(4):e1007012. https:\/\/doi.org\/10.1371\/journal.ppat.1007012","journal-title":"PLoS Pathog"},{"issue":"6","key":"12778_CR84","doi-asserted-by":"publisher","first-page":"e1010555","DOI":"10.1371\/journal.ppat.1010555","volume":"18","author":"B Lindqvist","year":"2022","unstructured":"Lindqvist B, Jutte BB, Love L, Assi W, Roux J, Sonnerborg A et al (2022) T cell stimulation remodels the latently HIV-1 infected cell population by differential activation of proviral chromatin. PLoS Pathog 18(6):e1010555. https:\/\/doi.org\/10.1371\/journal.ppat.1010555","journal-title":"PLoS Pathog"},{"issue":"667","key":"12778_CR85","doi-asserted-by":"publisher","first-page":"eabh3351","DOI":"10.1126\/scitranslmed.abh3351","volume":"14","author":"W Dai","year":"2022","unstructured":"Dai W, Wu F, McMyn N, Song B, Walker-Sperling VE, Varriale J et al (2022) Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir. Sci Transl Med 14(667):eabh3351. https:\/\/doi.org\/10.1126\/scitranslmed.abh3351","journal-title":"Sci Transl Med"},{"issue":"1","key":"12778_CR86","doi-asserted-by":"publisher","first-page":"e1011101","DOI":"10.1371\/journal.ppat.1011101","volume":"19","author":"E Hsieh","year":"2023","unstructured":"Hsieh E, Janssens DH, Paddison PJ, Browne EP, Henikoff S, OhAinle M et al (2023) A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency. PLoS Pathog 19(1):e1011101. https:\/\/doi.org\/10.1371\/journal.ppat.1011101","journal-title":"PLoS Pathog"},{"issue":"18","key":"12778_CR87","doi-asserted-by":"publisher","first-page":"13141","DOI":"10.1074\/jbc.R700001200","volume":"282","author":"SY Wu","year":"2007","unstructured":"Wu SY, Chiang CM (2007) The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem 282(18):13141\u201313145. https:\/\/doi.org\/10.1074\/jbc.R700001200","journal-title":"J Biol Chem"},{"issue":"4","key":"12778_CR88","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/10409238.2015.1061973","volume":"50","author":"MY Jeng","year":"2015","unstructured":"Jeng MY, Ali I, Ott M (2015) Manipulation of the host protein acetylation network by human immunodeficiency virus type 1. Crit Rev Biochem Mol Biol 50(4):314\u2013325. https:\/\/doi.org\/10.3109\/10409238.2015.1061973","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"12778_CR89","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12977-020-00547-9","volume":"18","author":"E Alamer","year":"2021","unstructured":"Alamer E, Zhong C, Hajnik R, Soong L, Hu H (2021) Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure. Retrovirology 18(1):3. https:\/\/doi.org\/10.1186\/s12977-020-00547-9","journal-title":"Retrovirology"},{"issue":"4","key":"12778_CR90","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4161\/cc.23679","volume":"12","author":"J Karn","year":"2013","unstructured":"Karn J (2013) A new BET on the control of HIV latency. Cell Cycle 12(4):545\u2013546. https:\/\/doi.org\/10.4161\/cc.23679","journal-title":"Cell Cycle"},{"issue":"3","key":"12778_CR91","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4161\/cc.23556","volume":"12","author":"AP Rice","year":"2013","unstructured":"Rice AP (2013) P-TEFb as a target to reactivate latent HIV: two Brds are now in hand. Cell Cycle 12(3):392\u2013393. https:\/\/doi.org\/10.4161\/cc.23556","journal-title":"Cell Cycle"},{"key":"12778_CR92","doi-asserted-by":"publisher","unstructured":"Salahong T, Schwartz C, Sungthong R (2021) Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy? Viruses 13(6). https:\/\/doi.org\/10.3390\/v13061026","DOI":"10.3390\/v13061026"},{"key":"12778_CR93","doi-asserted-by":"publisher","unstructured":"Tolomeo M, Cascio A (2026) Block-and-Lock Approaches for HIV Cure: Mechanistic Insights, Challenges, and Emerging Role of CPSF6. Int J Mol Sci 27(8). https:\/\/doi.org\/10.3390\/ijms27083496","DOI":"10.3390\/ijms27083496"},{"issue":"5","key":"12778_CR94","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/cmdc.201500540","volume":"11","author":"NH Theodoulou","year":"2016","unstructured":"Theodoulou NH, Tomkinson NC, Prinjha RK, Humphreys PG (2016) Progress in the Development of non-BET Bromodomain Chemical Probes. ChemMedChem 11(5):477\u2013487. https:\/\/doi.org\/10.1002\/cmdc.201500540","journal-title":"ChemMedChem"},{"key":"12778_CR95","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ebiom.2016.04.019","volume":"8","author":"VE Walker-Sperling","year":"2016","unstructured":"Walker-Sperling VE, Pohlmeyer CW, Tarwater PM, Blankson JN (2016) The Effect of Latency Reversal Agents on Primary CD8\u2009+\u2009T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication. EBioMedicine 8:217\u2013229. https:\/\/doi.org\/10.1016\/j.ebiom.2016.04.019","journal-title":"EBioMedicine"},{"key":"12778_CR96","doi-asserted-by":"publisher","unstructured":"Abner E, Stoszko M, Zeng L, Chen HC, Izquierdo-Bouldstridge A, Konuma T et al (2018) A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other Shock Drugs. J Virol 92(10). https:\/\/doi.org\/10.1128\/JVI.02056-17","DOI":"10.1128\/JVI.02056-17"},{"key":"12778_CR97","doi-asserted-by":"publisher","first-page":"686035","DOI":"10.3389\/fcimb.2021.686035","volume":"11","author":"T Zheng","year":"2021","unstructured":"Zheng T, Chen P, Huang Y, Qiu J, Zhou C, Wu Z et al (2021) CPI-637 as a Potential Bifunctional Latency-Reversing Agent That Targets Both the BRD4 and TIP60 Proteins. Front Cell Infect Microbiol 11:686035. https:\/\/doi.org\/10.3389\/fcimb.2021.686035","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"12778_CR98","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1172\/JCI120633","volume":"129","author":"Q Niu","year":"2019","unstructured":"Niu Q, Liu Z, Alamer E, Fan X, Chen H, Endsley J et al (2019) Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV. J Clin Invest 129(8):3361\u20133373. https:\/\/doi.org\/10.1172\/JCI120633","journal-title":"J Clin Invest"},{"key":"12778_CR99","doi-asserted-by":"publisher","unstructured":"Alamer E, Zhong C, Liu Z, Niu Q, Long F, Guo L et al (2020) Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580. J Virol 94(11). https:\/\/doi.org\/10.1128\/JVI.01880-19","DOI":"10.1128\/JVI.01880-19"},{"issue":"1","key":"12778_CR100","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1038\/s41467-025-59398-7","volume":"16","author":"E Pellaers","year":"2025","unstructured":"Pellaers E, Janssens J, Wils L, Denis A, Bhat A, Van Belle S et al (2025) BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription. Nat Commun 16(1):4226. https:\/\/doi.org\/10.1038\/s41467-025-59398-7","journal-title":"Nat Commun"},{"issue":"2","key":"12778_CR101","doi-asserted-by":"publisher","first-page":"e1013449","DOI":"10.1371\/journal.ppat.1013449","volume":"22","author":"N Kumar","year":"2026","unstructured":"Kumar N, Ma Z, Long F, Bonam SR, Lai HT, Wu SY et al (2026) Mechanistic insights and in vivo HIV suppression by the BRD4-targeting small molecule ZL0580. PLoS Pathog 22(2):e1013449. https:\/\/doi.org\/10.1371\/journal.ppat.1013449","journal-title":"PLoS Pathog"},{"key":"12778_CR102","doi-asserted-by":"publisher","unstructured":"Li G, Zhang Z, Reszka-Blanco N, Li F, Chi L, Ma J et al (2019) Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy. J Virol 93(12). https:\/\/doi.org\/10.1128\/JVI.00233-19","DOI":"10.1128\/JVI.00233-19"},{"issue":"1","key":"12778_CR103","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12985-024-02343-9","volume":"21","author":"JK Kisaka","year":"2024","unstructured":"Kisaka JK, Rauch D, Griffith M, Kyei GB (2024) A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis. Virol J 21(1):80. https:\/\/doi.org\/10.1186\/s12985-024-02343-9","journal-title":"Virol J"},{"issue":"4","key":"12778_CR104","doi-asserted-by":"publisher","first-page":"e0177724","DOI":"10.1128\/jvi.01777-24","volume":"99","author":"AM Turner","year":"2025","unstructured":"Turner AM, Bashore FM, Falcinelli SD, Fox JA, Keller AL, Fenton AD et al (2025) BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4\u2009+\u2009T-cells. J Virol 99(4):e0177724. https:\/\/doi.org\/10.1128\/jvi.01777-24","journal-title":"J Virol"},{"issue":"1","key":"12778_CR105","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1038\/s41598-025-33437-1","volume":"16","author":"ES Geanes","year":"2026","unstructured":"Geanes ES, Greening G, Aggelakopoulou M, Truong LH, Khanal S, LeMaster C et al (2026) Bromodomain and extra-terminal protein inhibitors modulate natural killer cell function and differentiation. Sci Rep 16(1):3465. https:\/\/doi.org\/10.1038\/s41598-025-33437-1","journal-title":"Sci Rep"},{"key":"12778_CR106","doi-asserted-by":"publisher","first-page":"112426","DOI":"10.1016\/j.ejmech.2020.112426","volume":"200","author":"D Liang","year":"2020","unstructured":"Liang D, Yu Y, Ma Z (2020) Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery. Eur J Med Chem 200:112426. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112426","journal-title":"Eur J Med Chem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12778-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12778-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12778-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:41:42Z","timestamp":1790077302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12778-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12778"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12778-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. The UNAM Research Ethics Committee has confirmed that no ethical approval is required for this research.","order":3,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mohammad Mehdi Akbarin, Zahra Farjami, and Hugo Ram\u00edrez \u00c1lvarez declare that they have no conflict of interest.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1603"}}